BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 33780166)

  • 1. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy.
    Pensato U; Muccioli L; Cani I; Janigro D; Zinzani PL; Guarino M; Cortelli P; Bisulli F
    Ann Clin Transl Neurol; 2021 Apr; 8(4):968-979. PubMed ID: 33780166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in CAR T Cell-Associated Neurotoxicity.
    Gust J; Ponce R; Liles WC; Garden GA; Turtle CJ
    Front Immunol; 2020; 11():577027. PubMed ID: 33391257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)-T-Cell therapy.
    Hoyt R; Ye Z; Dasgupta A
    Clin Chim Acta; 2024 Jun; 559():119704. PubMed ID: 38697457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-centers experience using therapeutic plasma exchange for corticosteroid/tocilizumab-refractory cytokine release syndrome following CAR-T therapy.
    Pu Y; Zhao Y; Qi Y; Liu Y; Zhang M; Xiao X; Lyu H; Meng J; Zhu H; Xu K; Han W; Zhao M
    Int Immunopharmacol; 2024 Mar; 130():111761. PubMed ID: 38422769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging Features of Cytokine-related Diseases.
    Kurokawa M; Kurokawa R; Baba A; Gomi T; Cho S; Yoshioka K; Harada T; Kim J; Emile P; Abe O; Moritani T
    Radiographics; 2024 Jun; 44(6):e230069. PubMed ID: 38696321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 cytokine storm and novel truth.
    Sultan S; Sultan M
    Med Hypotheses; 2020 Nov; 144():109875. PubMed ID: 32593830
    [No Abstract]   [Full Text] [Related]  

  • 7. The Multifaceted Immunology of Cytokine Storm Syndrome.
    Lee PY; Cron RQ
    J Immunol; 2023 Apr; 210(8):1015-1024. PubMed ID: 37011407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine Storm Related to CD4
    Wang S; Wang D; Wang X; Chen M; Wang Y; Zhou H; Zhou Y; Lv Y; Wei H
    Immune Netw; 2024 Apr; 24(2):e18. PubMed ID: 38725671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shelter from the cytokine storm in myelofibrosis.
    Lane SW
    Blood; 2023 May; 141(20):2415-2416. PubMed ID: 37200061
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrical storm in a febrile patient with Brugada syndrome and COVID-19 infection.
    Maglione TJ; Aboyme A; Ghosh BD; Bhatti S; Kostis WJ
    HeartRhythm Case Rep; 2020 Oct; 6(10):676-679. PubMed ID: 32837908
    [No Abstract]   [Full Text] [Related]  

  • 11. GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
    Favalli EG; Caporali R
    Lancet Rheumatol; 2020 Aug; 2(8):e448-e449. PubMed ID: 33521666
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytokine Storm: The Novel Mechanism for Sleep Deprivation-induced Multiple Organ Dysfunction Syndrome.
    Wang L; Liu H; Qin L; Li L
    Neurosci Bull; 2024 May; ():. PubMed ID: 38702450
    [No Abstract]   [Full Text] [Related]  

  • 13. Encephalopathy responsive to thiamine in severe COVID-19 patients.
    Branco de Oliveira MV; Irikura S; Lourenço FHB; Shinsato M; Irikura TCDB; Irikura RB; Albuquerque TVC; Shinsato VN; Orsatti VN; Fontanelli AM; Samegima DAG; Gonçalves MVM; Bernabé DG
    Brain Behav Immun Health; 2021 Jul; 14():100252. PubMed ID: 33817670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia.
    Li C; Cao W; Que Y; Wang Q; Xiao Y; Gu C; Wang D; Wang J; Jiang L; Xu H; Xu J; Zhou X; Hong Z; Wang N; Huang L; Zhang S; Chen L; Mao X; Xiao M; Zhang W; Meng L; Cao Y; Zhang T; Li J; Zhou J
    Clin Transl Med; 2021 Mar; 11(3):e346. PubMed ID: 33784005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response?
    Pensato U; Muccioli L; Janigro D; Guarino M; Bisulli F; Cortelli P
    Brain Behav Immun Health; 2021 Aug; 15():100272. PubMed ID: 34002170
    [No Abstract]   [Full Text] [Related]  

  • 16. Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs.
    Moghanloo E; Mollanoori H; Talebi M; Pashangzadeh S; Faraji F; Hadjilooei F; Mahmoodzadeh H
    Transl Oncol; 2021 Jun; 14(6):101070. PubMed ID: 33789222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Neurologic Complications of SARS-CoV-2.
    Sisniega DC; Reynolds AS
    Curr Treat Options Neurol; 2021; 23(5):14. PubMed ID: 33814894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Complications of COVID-19: Underlying Mechanisms and Management.
    Shehata GA; Lord KC; Grudzinski MC; Elsayed M; Abdelnaby R; Elshabrawy HA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management.
    Burns EA; Gentille C; Trachtenberg B; Pingali SR; Anand K
    Diseases; 2021 Mar; 9(1):. PubMed ID: 33802788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric Antigen Receptor T-Cell Emergencies: Inpatient Administration, Assessment, and Management.
    Jackson S; Wheatley T
    Semin Oncol Nurs; 2021 Apr; 37(2):151134. PubMed ID: 33795179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.